Treatment for Hip Revision Surgery

Phase-Based Progress Estimates
Hip Revision Surgery
18 - 85
All Sexes
What conditions do you have?

Study Summary

This trial will compare the long-term outcomes of two types of hip replacement surgeries.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: 5 years

5 years
Number of cases that had successful revision with Trident II Acetabular Shell of a Total Hip Replacement
Year 10
Radiographic Migration
Radiographic Radiolucency

Trial Safety

Safety Progress

1 of 3

Trial Design

0 Treatment Group

347 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 5 years

Who is running the clinical trial?

Stryker OrthopaedicsLead Sponsor
60 Previous Clinical Trials
18,471 Total Patients Enrolled

Eligibility Criteria

Age 18 - 85 · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are willing and able to comply with postoperative scheduled clinical and radiographic evaluations.
You have been informed that you will be asked to participate in this study.\n
Patient is a candidate for a revision of a failed acetabular component with a cementless acetabular component.